Acute cardiac care & resuscitation

Kidney Injury in Patients with Heart Failure-Related Cardiogenic Shock: Results from an International, Multicentre Cohort Study

Eur J Heart FailPublished Retrospective cohort study

Main finding · 30-day mortality by AKI stageResult — go to the resultAdjusted hazard ratio 1.97 95% CI 1.56–2.48

Authors' conclusion

In HF-CS, kidney injury is associated with higher 30-day mortality, potentially mediated by bleeding and sepsis.

Study context

Population
Patients with heart failure-related cardiogenic shock (HF-CS), 2010–2021
Participants
1,010 patients
Exposure
Acute kidney injury (AKI) stages and severe renal dysfunction vs none
Outcome
30-day mortality by renal function
Follow-up
30 days
Methodological detailsmulticentre, international, 16 tertiary care centres in five countries
  • Multicentre
  • International
  • 16 tertiary care centres in five countries

Main finding

30-day mortality by AKI stage

Adjusted hazard ratio

1.97

95% CI 1.56–2.48

P < 0.001

By group

AKI stage 3vs No AKI
adjusted HR 1.97 (95% CI 1.56–2.48); P < 0.001

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeSevere renal dysfunctionNo severe renal dysfunctionAdjusted HR (95% CI)P value
30-day mortality by severe renal dysfunction (eGFR ≤ median) · 21% higher 30-day mortality risk61.0%40.1%1.48 (1.20–1.84)P < 0.001

Baseline renal function · median baseline

Median baseline creatinine
1.7 (IQR 1.2-2.5) mg/dl
Corresponding estimated glomerular filtration rate (eGFR)
41.0 (IQR 25.2-62.2) ml/min/1.73 m²

Sepsis and bleeding

Sepsis and bleeding associated with both AKI and renal dysfunction, even after adjustment

Original publication

Kidney Injury in Patients with Heart Failure-Related Cardiogenic Shock: Results from an International, Multicentre Cohort Study. Eur J Heart Fail. Published 28 May 2025. doi:10.1002/ejhf.3701

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.